Skip to main content
Top
Published in: Diseases of the Colon & Rectum 3/2004

01-03-2004 | Original Contribution

Rate of Pathologic Complete Response With Increased Interval Between Preoperative Combined Modality Therapy and Rectal Cancer Resection

Authors: Harvey G. Moore, M.D., Alicia E. Gittleman, M.D., Bruce D. Minsky, M.D., Douglas Wong, M.D., Philip B. Paty, M.D., Martin Weiser, M.D., Larissa Temple, M.D., Leonard Saltz, M.D., Jinru Shia, M.D., Jose G. Guillem, M.D., M.P.H.

Published in: Diseases of the Colon & Rectum | Issue 3/2004

Login to get access

INTRODUCTION

Recent data suggest a favorable prognosis for rectal cancer patients with a pathologic complete response to preoperative combined modality therapy. Prolongation of the interval between preoperative combined modality therapy and surgery (RT-surgery interval) as a means of increasing pathologic complete response rate has not been fully examined.

METHODS

One hundred and fifty-five rectal cancer patients undergoing preoperative pelvic external beam radiation therapy and 5-fluorouracil-based chemotherapy followed by rectal resection were identified. All patients had endorectal ultrasound prior to combined modality therapy. Final pathology reports were reviewed for ypT and ypN stage and margin status. Medical records were reviewed for sphincter preservation, operative time, estimated blood loss, hospital stay, and morbidity (overall, anastomotic, and perineal).

RESULTS

A pathologic complete response (ypT0N0) occurred in 24 patients (15 percent). Median RT-surgery interval was 44 (range, 15-206) days. A pathologic complete response occurred in 19 percent of patients with an interval >44 days, vs. 12 percent in those with an interval ≤44 days (P = 0.27). Downstaging by three stages occurred more frequently in the long-interval group (15 percent vs. 6 percent, P = 0.11). The rates of sphincter preservation, positive margins, estimated blood loss, and operative time were not significantly different. Overall morbidity was similar between groups.

CONCLUSIONS

Our results demonstrate a trend toward increased pathologic complete response rate and downstaging with increased RT-surgery interval. However, sphincter preservation is not increased. Until prospective analyses are conducted assessing the impact of prolonged RT-surgery interval on long-term outcome, the benefit of a prolonged interval between the completion of preoperative combined modality therapy and surgery remains unclear.
Literature
1.
go back to reference Kapiteijn, E, Marijnen, CA, Nagtegaal, ID, et al. 2001Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancerN Engl J Med34563846 Kapiteijn, E, Marijnen, CA, Nagtegaal, ID,  et al. 2001Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancerN Engl J Med34563846
2.
go back to reference Colorectal Cancer Collaborative Group2001Adjuvant radiotherapy for rectal cancer: a systematic overview of 8,507 patients from 22 randomised trialsLancet3581291304 Colorectal Cancer Collaborative Group2001Adjuvant radiotherapy for rectal cancer: a systematic overview of 8,507 patients from 22 randomised trialsLancet3581291304
3.
go back to reference Ruo, L, Guillem, JG, Tickoo, S, et al. 2002Long-term prognostic significance of extent of rectal cancer response to preoperative radiation +/− chemotherapyAnn Surg2367581 Ruo, L, Guillem, JG, Tickoo, S,  et al. 2002Long-term prognostic significance of extent of rectal cancer response to preoperative radiation +/− chemotherapyAnn Surg2367581
4.
go back to reference Garcia-Aguilar, J, Hernandez de Anda, E, Sirivongs, P, Lee, SH, Madoff, RD, Rothenberger, DA 2003A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excisionDis Colon Rectum46298304 Garcia-Aguilar, J, Hernandez de Anda, E, Sirivongs, P, Lee, SH, Madoff, RD, Rothenberger, DA 2003A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excisionDis Colon Rectum46298304
5.
go back to reference Mohiuddin, M, Regine, WF, John, WJ, et al. 2000Preoperative chemoradiation in fixed distal rectal cancer: dose time factors for pathological complete responseInt J Radiat Oncol Biol Phys468838 Mohiuddin, M, Regine, WF, John, WJ,  et al. 2000Preoperative chemoradiation in fixed distal rectal cancer: dose time factors for pathological complete responseInt J Radiat Oncol Biol Phys468838
6.
go back to reference Chan, AK, Wong, AO, Langevin, J, et al. 2000Preoperative chemotherapy and pelvic radiation for tethered or fixed rectal cancer: a phase II dose escalation studyInt J Radiat Oncol Biol Phys4884356 Chan, AK, Wong, AO, Langevin, J,  et al. 2000Preoperative chemotherapy and pelvic radiation for tethered or fixed rectal cancer: a phase II dose escalation studyInt J Radiat Oncol Biol Phys4884356
7.
go back to reference Myerson, RJ, Valentini, V, Birnbaum, EH, et al. 2001A phase I/II trial of three-dimensionally planned concurrent boost radiotherapy and protracted venous infusion of 5-FU chemotherapy for locally advanced rectal carcinomaInt J Radiat Oncol Biol Phys501299308 Myerson, RJ, Valentini, V, Birnbaum, EH,  et al. 2001A phase I/II trial of three-dimensionally planned concurrent boost radiotherapy and protracted venous infusion of 5-FU chemotherapy for locally advanced rectal carcinomaInt J Radiat Oncol Biol Phys501299308
8.
go back to reference Anscher, MS, Lee, C, Hurwitz, H, et al. 2000A pilot study of preoperative continuous infusion 5-fluorouracil, external microwave hyperthermia, and external beam radiotherapy for treatment of locally advanced, unresectable, or recurrent rectal cancerInt J Radiat Oncol Biol Phys4771924 Anscher, MS, Lee, C, Hurwitz, H,  et al. 2000A pilot study of preoperative continuous infusion 5-fluorouracil, external microwave hyperthermia, and external beam radiotherapy for treatment of locally advanced, unresectable, or recurrent rectal cancerInt J Radiat Oncol Biol Phys4771924
9.
go back to reference Videtic, GM, Fisher, BJ, Perera, FE, et al. 1998Preoperative radiation with concurrent 5-fluorouracil continuous infusion for locally advanced unresectable rectal cancerInt J Radiat Oncol Biol Phys4231924 Videtic, GM, Fisher, BJ, Perera, FE,  et al. 1998Preoperative radiation with concurrent 5-fluorouracil continuous infusion for locally advanced unresectable rectal cancerInt J Radiat Oncol Biol Phys4231924
10.
go back to reference Ngan, SY, Burmeister, BH, Fisher, R, et al. 2001Early toxicity from preoperative radiotherapy with continuous infusion 5-fluorouracil for resectable adenocarcinoma of the rectum: a Phase II trial for the Trans-Tasman Radiation Oncology GroupInt J Radiat Oncol Biol Phys508837 Ngan, SY, Burmeister, BH, Fisher, R,  et al. 2001Early toxicity from preoperative radiotherapy with continuous infusion 5-fluorouracil for resectable adenocarcinoma of the rectum: a Phase II trial for the Trans-Tasman Radiation Oncology GroupInt J Radiat Oncol Biol Phys508837
11.
go back to reference Janjan, NA, Crane, C, Feig, BW, et al. 2001Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancerAm J Clin Oncol2410712 Janjan, NA, Crane, C, Feig, BW,  et al. 2001Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancerAm J Clin Oncol2410712
12.
go back to reference Grann, A, Feng, C, Wong, D, et al. 2001Preoperative combined modality therapy for clinically resectable uT3 rectal adenocarcinomaInt J Radiat Oncol Biol Phys4998795 Grann, A, Feng, C, Wong, D,  et al. 2001Preoperative combined modality therapy for clinically resectable uT3 rectal adenocarcinomaInt J Radiat Oncol Biol Phys4998795
13.
go back to reference Minsky, BD, Cohen, AM, Enker, WE, et al. 1997Preoperative 5-FU, low-dose leucovorin, and radiation therapy for locally advanced and unresectable rectal cancerInt J Radiat Oncol Biol Phys3728995 Minsky, BD, Cohen, AM, Enker, WE,  et al. 1997Preoperative 5-FU, low-dose leucovorin, and radiation therapy for locally advanced and unresectable rectal cancerInt J Radiat Oncol Biol Phys3728995
14.
go back to reference Minsky, BD, Oreilly, E, Wong, D, et al. 1999Daily low-dose irinotecan (CPT-11) plus pelvic irradiation as preoperative treatment of locally advanced rectal cancerProc ASCO18266a Minsky, BD, Oreilly, E, Wong, D,  et al. 1999Daily low-dose irinotecan (CPT-11) plus pelvic irradiation as preoperative treatment of locally advanced rectal cancerProc ASCO18266a
15.
go back to reference Stein, DE, Mahmoud, NN, Anne, PR, et al. 2003Longer time interval between completion of neoadjuvant chemoradiation and surgical resection does not improve downstaging of rectal carcinomaDis Colon Rectum4644853 Stein, DE, Mahmoud, NN, Anne, PR,  et al. 2003Longer time interval between completion of neoadjuvant chemoradiation and surgical resection does not improve downstaging of rectal carcinomaDis Colon Rectum4644853
16.
go back to reference Ratto, C, Valentini, V, Morganti, AG, et al. 2003Combined-modality therapy in locally advanced primary rectal cancerDis Colon Rectum465967 Ratto, C, Valentini, V, Morganti, AG,  et al. 2003Combined-modality therapy in locally advanced primary rectal cancerDis Colon Rectum465967
17.
go back to reference Valentini, V, Coco, C, Cellini, N, et al. 2001Ten years of preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, and sphincter preservation in three consecutive studiesInt J Radiat Oncol Biol Phys5137183 Valentini, V, Coco, C, Cellini, N,  et al. 2001Ten years of preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, and sphincter preservation in three consecutive studiesInt J Radiat Oncol Biol Phys5137183
18.
go back to reference Kim, JS, Cho, MJ, Song, KS, Yoon, WH 2002Preoperative chemoradiation using oral capecitabine in locally advanced rectal cancerInt J Radiat Oncol Biol Phys544038 Kim, JS, Cho, MJ, Song, KS, Yoon, WH 2002Preoperative chemoradiation using oral capecitabine in locally advanced rectal cancerInt J Radiat Oncol Biol Phys544038
19.
go back to reference Marijnen, CA, Nagtegaal, ID, Klein Kranenbarg, E, et al. 2001No downstaging after short-term preoperative radiotherapy in rectal cancer patientsJ Clin Oncol19197684 Marijnen, CA, Nagtegaal, ID, Klein Kranenbarg, E,  et al. 2001No downstaging after short-term preoperative radiotherapy in rectal cancer patientsJ Clin Oncol19197684
20.
go back to reference Francois, Y, Nemoz, CJ, Baulieux, J, et al. 1999Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trialJ Clin Oncol172396402 Francois, Y, Nemoz, CJ, Baulieux, J,  et al. 1999Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trialJ Clin Oncol172396402
21.
go back to reference Grann, A, Minsky, BD, Cohen, AM, et al. 1997Preliminary results of preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for clinically resectable T3 rectal cancerDis Colon Rectum4051522 Grann, A, Minsky, BD, Cohen, AM,  et al. 1997Preliminary results of preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for clinically resectable T3 rectal cancerDis Colon Rectum4051522
22.
go back to reference Glehen, O, Chapet, O, Adham, M, Nemoz, JC, Gerard, JP 2003Long-term results of the Lyons R90-01 randomized trial of preoperative radiotherapy with delayed surgery and its effect on sphincter-saving surgery in rectal cancerBr J Surg909968 Glehen, O, Chapet, O, Adham, M, Nemoz, JC, Gerard, JP 2003Long-term results of the Lyons R90-01 randomized trial of preoperative radiotherapy with delayed surgery and its effect on sphincter-saving surgery in rectal cancerBr J Surg909968
Metadata
Title
Rate of Pathologic Complete Response With Increased Interval Between Preoperative Combined Modality Therapy and Rectal Cancer Resection
Authors
Harvey G. Moore, M.D.
Alicia E. Gittleman, M.D.
Bruce D. Minsky, M.D.
Douglas Wong, M.D.
Philip B. Paty, M.D.
Martin Weiser, M.D.
Larissa Temple, M.D.
Leonard Saltz, M.D.
Jinru Shia, M.D.
Jose G. Guillem, M.D., M.P.H.
Publication date
01-03-2004
Publisher
Springer-Verlag
Published in
Diseases of the Colon & Rectum / Issue 3/2004
Print ISSN: 0012-3706
Electronic ISSN: 1530-0358
DOI
https://doi.org/10.1007/s10350-003-0062-1

Other articles of this Issue 3/2004

Diseases of the Colon & Rectum 3/2004 Go to the issue